Onderneming Lincoln Pharmaceuticals Limited NSE India S.E.
Aandelen
LINCOLN
INE405C01035
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
568,6 INR | -1,57% | +0,01% | -6,71% |
Vakgebied
Aantal werknemers: 1 645
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 4 721 | 100,0 % | 5 103 | 100,0 % | +8,09% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Rest of World
57,4
%
| 2 665 | 56,5 % | 2 931 | 57,4 % | +9,96% |
India
42,6
%
| 2 056 | 43,5 % | 2 172 | 42,6 % | +5,65% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 20-01-95 | |
Director of Finance/CFO | - | 28-03-19 | |
Chief Tech/Sci/R&D Officer | - | - | |
Compliance Officer | 30 | 10-11-22 | |
Chief Administrative Officer | - | - | |
Dhaval Gandhi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director/Board Member | 43 | - | |
Director/Board Member | 41 | 14-11-14 | |
Director/Board Member | 66 | 20-01-95 | |
Bhavesh Patel
SAM | Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 20-01-95 | |
Chairman | 80 | 16-08-95 | |
Director/Board Member | 66 | 20-01-95 | |
Director/Board Member | 41 | 14-11-14 | |
Director/Board Member | 43 | - | |
Director/Board Member | 52 | 27-03-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 20 029 728 | 8 642 988 ( 43,15 %) | 0 | 43,15 % |
Bedrijfsgegevens
Lincoln Pharmaceuticals Ltd.
Lincoln House Behind Satyam Complex
380060, Ahmedabad
+91 79 4107 8000
http://www.lincolnpharma.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,36% | 705 mld. | |
+32,82% | 583 mld. | |
-3,74% | 364 mld. | |
+19,89% | 332 mld. | |
+4,92% | 291 mld. | |
+16,64% | 238 mld. | |
-4,13% | 210 mld. | |
+10,63% | 209 mld. | |
+8,82% | 169 mld. |
- Beurs
- Aandelen
- Koers LINCOLN
- Koers LINCOLN
- Onderneming Lincoln Pharmaceuticals Limited